Prof Mekhail speaks with ecancer at NOSCM 2017 targeted therapies for lung cancer. He looks beyond EGFR and ALK mutations to emerging targets in lung cancer including BRAF and HER2, which have significant histories in other disease but are now...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vJeA3V
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers British Journal of Cancer 116, 1425 (23 May 2017). ...
-
Objective A systematic review and meta-analysis to investigate the impact of electronic nicotine delivery systems (ENDS) and/or electronic n...
-
Publication date: April 2017 Source: European Journal of Cancer, Volume 75 Author(s): A. Ieni, G. Angelico, P. Zeppa, G. Tuccari fro...
-
Publication date: October 2017 Source: International Journal of Biological Macromolecules, Volume 103 Author(s): Shehwaz Anwar, Hina Youn...
-
Related Articles Modulation of the Tumor Microenvironment by Epstein-Barr virus Latent Membrane Protein-1 in Nasopharyngeal Carcinoma....
-
Abstract To estimate the prevalence and features of metabolic syndrome (MetS) in childhood-onset systemic lupus erythematosus (cSLE), we p...
-
Abstract The quantitative evaluation of Social Science and Humanities (SSH) and the investigation of the existing similarities between SSH...
-
ABSTRACT In this review the structural and functional imaging changes associated with the synucleinopathies PD, MSA, and dementias associa...
-
Lanthanide-Doped Nanoparticles for Diagnostic Sensing. Nanomaterials (Basel). 2017 Nov 23;7(12): Authors: Lee SY, Lin M, Lee A, Park ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου